+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Global Fertility Supplements Market Size was valued at USD 1.4 Billion in 2022. The Fertility Supplements market industry is projected to grow from USD 2.2 Billion in 2023 to USD 4.4 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.55% during the forecast period (2023 - 2032). Declining fertility rates brought on by an increase in smokers, as well as by drinking more alcohol and using more caffeine, are the key market drivers enhancing the market growth.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
It is projected that market growth in the upcoming years will be fueled by rising alcohol and caffeine intake as well as a rise in smokers, which has resulted in a drop in birth rates. Rising healthcare costs, altering lifestyles, new food innovations, and medical developments have all increased demand for the product. Due to women delaying pregnancies and continued fertility rate reductions, the market for fertility supplements is growing on a global scale. Since it was discovered that the COVID-19 virus affected a person's degree of fertility, the COVID-19 pandemic had a favorable effect on the market for fertility supplements. Zinc supplementation may help minimize or prevent damage to egg and sperm cells brought on by the body's immunological response to the coronavirus, according to the study "Potential Role of Zinc in the COVID-19 Disease Process and its Probable Impact on Reproduction" published in January 2021. This study raised consumer demand for reproductive supplements during the epidemic, which was good for business.
It is projected that the market for functional foods and beverages will grow soon, which could potentially obstruct the growth of the entire industry. More and more people are using foods like olive oil, healthy grains, avocados, and high-fat dairy items to increase fertility. Although it is predicted that consumers' concerns about the negative side effects of conventional pharmaceutical drugs will lead to a growth in the use of herbal (or botanical) medicines, this will be positive for product manufacturers. Consumers are now more likely to take supplements based on what is best for their health rather than appealing marketing and packaging thanks to a number of government programs to promote knowledge of the breakthroughs in supplement research and cutting-edge technologies.
Consumer desire for infertility prevention methods including eating a balanced diet and taking more nutritional supplements is fueling industry growth. The rise in infertility rates is also attributed to a number of illnesses, including sexually transmitted diseases (STDs) and conditions that affect fertility. As a result, it is anticipated that as infertility rates rise, the market for fertility supplements would grow more fast in the near future. Consumers in Argentina and Brazil have recently placed a high priority on enhancing their sexual health and wellbeing. As a result, people are more inclined to spend money on worthwhile endeavors. As a result, it is anticipated that demand for fertility drugs will rise over the coming years. Thus, driving the Fertility Supplements market revenue.
The global Fertility Supplements market segmentation, based on Ingredient, includes natural and synthetic/ blend of natural & synthetic. Synthetic segment dominated the global market in 2022. The primary synthetic ingredients—selenium, zinc, folic acid, vitamin C, vitamin B6, CoQ1, and myo-inositol—contributed significantly to overall expansion due to growing demand and easy accessibility.
The global Fertility Supplements market segmentation, based on Product, includes capsules, tablets, soft gels, powder, and liquids. The capsules segment dominated the global market in 2022. This is due to increased awareness of the nutritional benefits these products offer, in addition to their exquisite flavors and straightforward use in meals. These products guarantee the absorption of fat- and oil-soluble nutrients, enable creative component pairings, ease gastrointestinal pain, and protect consumers from sensitive substances.
The global Fertility Supplements market segmentation, based on End Use, includes men and women. Women segment dominated the global Fertility Supplements market in 2022. The Centres for Disease Control and Prevention estimate that 19% of women between the ages of 15 and 49 who have never given birth struggle with infertility. However, the prevalence of reproductive issues was highest among married, infertile women between the ages of 40 and 44 and 35 to 39. Initiatives by the government and nonprofit organizations to provide support and medical care have helped to increase awareness and open up new markets for product manufacturers.
The global Fertility Supplements market segmentation, based on Distribution Channel, includes OTC and prescribed. The OTC segment dominated the global Fertility Supplements market in 2022. Because of the rising demand, easy access to raw materials, and low restrictions, the market is fragmented. If businesses wish to survive in this highly competitive industry, they must concentrate on introducing FDA-regulated components that have passed a significant number of clinical trials or research. One of the key developments in the OTC industry is self-medication for the treatment of infertility issues. Additionally, it is projected that in the near future, qualities like the affordability and simplicity of direct purchasing would be advantageous to producers of over-the-counter fertility supplements.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
Insights into the markets in North America, Europe, Asia-Pacific, and the rest of the world are provided by the study. In 2022, this market was dominated by the North America Fertility Supplements Market (45.80%). According to data from the Centers for Disease Control and Prevention (CDC) December 2021 update, 13.1% of women between the ages of 15 and 49 in the United States had impaired fertility, 14.1% of married women between the ages of 15 and 49 had impaired fertility, and 6% of married women were found to be infertile. Due to this, local product demand grew. Further, In the North American area, the U.S. Fertility Supplements market had the biggest market share, while the Canada Fertility Supplements market had the quickest rate of expansion.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
In 2022, Europe held a sizable market share for fertility supplements. Leading companies in the fertility supplement market have profitable opportunities in the region because of the increased accessibility and availability of healthcare facilities as well as the increased investment in the research and healthcare sectors. Further, In the European region, the German Fertility Supplements market had the biggest market share, and the U.K. Fertility Supplements market had the quickest rate of growth.
From 2023 to 2032, the Asia Pacific Fertility Supplements market is anticipated to grow significantly. Growing awareness of nutritional augmentation is anticipated to be a major factor in regional growth in both China and India. The rise of the retail industry in countries like India, China, Indonesia, and Malaysia as a consequence of governmental support for investment is also predicted to boost customer accessibility throughout the course of the projection period. This will support local market growth. Moreover, In the Asia-Pacific region, the Indian Fertility Supplements market had the quickest rate of growth while China's Fertility Supplements market had the greatest market share.
Leading industry companies are making significant R&D investments in order to diversify their product offerings, which will drive the Fertility Supplements market's expansion. Important market developments include new product releases, contractual agreements, mergers and acquisitions, greater investments, and collaboration with other organizations. Market participants are also engaging in a number of strategic actions to increase their global footprint. The Fertility Supplements sector needs to provide affordable products if it wants to grow and thrive in a more competitive and challenging market environment.
One of the primary business strategies employed by manufacturers in the worldwide Fertility Supplements industry to assist customers and expand the market sector is local manufacturing to reduce operational costs. Some of the biggest benefits to medicine have recently come from the Fertility Supplements sector. Major players in the Fertility Supplements market, including Fairhaven Health, Coast Science, Lenus Pharma GesmbH, Active Bio Life Science GmbH, Orthomol, Exeltis USA, Inc., PregPrep LLC, Bionova, Vitabiotics Ltd., TTK Healthcare Ltd., Fertility Nutraceuticals LLC, extreme V, Inc., VH Nutrition LLC, CellOxess LLC, Gonadosan, Amino Expert (Innovamed Ltd.), Babystart Ltd., Crown Nutraceuticals, Sal Nature, and YadTech, are attempting to increase market demand by investing in research and development Products.
Wellbeing Nutrition is a manufacturer of wellness products with a health-related focus. Customers can obtain natural ingredients that are healthy and preserved without preservatives through the company's food offerings, which also include vitamins, performance packs, hair packs, hair care kits, and other related products. SLOW, a line of time-conscious nutraceuticals for both men and women, was introduced by Wellbeing Nutrition in April 2022. It consists of 13 supplements, each of which is designed to particularly address a certain wellness or health need, such assisting with conception.
EMD Serono is a biotechnology company that finds and develops biopharmaceutical products. It focuses on specialized areas such neurological disorders, cancer, metabolic endocrinology, and fertility. The company was founded in 1971, and Rockland, Massachusetts serves as its headquarters. It looks to acquire other companies in the same industry in order to progress further and diversify its product line. EMD Serono, a unit of Merck KGaA that focuses on healthcare, unveiled the Slim Pack reproductive medication packaging in February 2022. Scaling up this packaging has advantages for both convenience and the environment. We want to improve effectiveness, portability, and convenience with this launch.
· Fairhaven Health
· Coast Science
· Lenus Pharma GesmbH
· Active Bio Life Science GmbH
· Orthomol
· Exeltis USA, Inc.
· PregPrep LLC
· Bionova,
· Vitabiotics Ltd.
· TTK Healthcare Ltd.
· Fertility Nutraceuticals LLC
· extreme V, Inc.
· VH Nutrition LLC
· CellOxess LLC
· Gonadosan
· Amino Expert (Innovamed Ltd.)
· Babystart Ltd.
· Crown Nutraceuticals
· Sal Nature
· YadTech
April 2022: Ovaterra by Fertility Nutraceuticals, a provider of reproductive health products, has launched two new prenatal vitamin supplements. These prenatal capsules come in individual serving sizes and are made to have the recommended quantity of choline for pregnant and breastfeeding women.
· Natural
· Synthetic/ Blend of Natural & Synthetic
· Capsules
· Tablets
· Soft Gels
· Powder
· Liquids
· Men
· Women
· OTC
· Prescribed
· North America
- US
- Canada
· Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
· Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
· Rest of the World
- Middle East
- Africa
- Latin America
|
Report Attribute/Metric |
Details |
|
Market Size 2022 |
USD 1.4 Billion |
|
Market Size 2023 |
USD 2.2 Billion |
|
Market Size 2032 |
USD 4.4 Billion |
|
Compound Annual Growth Rate (CAGR) |
8.55% (2023-2032) |
|
Base Year |
2022 |
|
Market Forecast Period |
2023-2032 |
|
Historical Data |
2018- 2022 |
|
Market Forecast Units |
Value (USD Billion) |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
Ingredient, Product, End Use, Distribution Channel, and Region |
|
Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
|
Countries Covered |
The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
|
Key Companies Profiled |
Fairhaven Health, Coast Science, Lenus Pharma GesmbH, Active Bio Life Science GmbH, Orthomol, Exeltis USA, Inc., PregPrep LLC, Bionova, Vitabiotics Ltd., TTK Healthcare Ltd., Fertility Nutraceuticals LLC, extreme V, Inc., VH Nutrition LLC, CellOxess LLC, Gonadosan, Amino Expert (Innovamed Ltd.), Babystart Ltd., Crown Nutraceuticals, Sal Nature, and YadTech |
|
Key Market Opportunities |
Rising demand for natural ingredients |
|
Key Market Dynamics |
The declining fertility rates brought on by the rise in the number of smokers and the rising consumption of alcohol and caffeine |
The global Fertility Supplements market size was valued at USD 1.4 Billion in 2022.
The global market is projected to grow at a CAGR of 8.55% during the forecast period, 2023-2032.
North America had the largest share in the global market
The key players in the market are Fairhaven Health, Coast Science, Lenus Pharma GesmbH, Active Bio Life Science GmbH, Orthomol, Exeltis USA, Inc., PregPrep LLC, Bionova, Vitabiotics Ltd., TTK Healthcare Ltd., Fertility Nutraceuticals LLC, extreme V, Inc., VH Nutrition LLC, CellOxess LLC, Gonadosan, Amino Expert (Innovamed Ltd.), Babystart Ltd., Crown Nutraceuticals, Sal Nature, and YadTech
The Synthetic Ingredient dominated the market in 2022.
The Capsules Product had the largest share in the global market.
Report Code :
RL65122
Published on :
Aug 2023
Request a Free Sample Report
Speak to Analyst